Adolfson et al., “Iodine-125 Brachytherapy for clinically localized prostate cancer: A 5-year follow-up of outcome and complications,” Eur. Urol. 26:207-211 (1994). |
Baidoo et al., “99mTc labeling of proteins: Initial evaluation of a novel diaminedithiol bifunctional chelating agent,” Cancer Research 50:799s-800s (1990). |
Chen et al., “A bifunctional ligand for Pd(II),” Nucl. Med. Biol. 13:369-372 (1986). |
Conway et al., “Palladium (II)-catalyzed olfein-coupling reactions of kainic acid: Effects of substitution on the isopropenyl group on receptor binding,” J. Med. Chem. 27:52-56 (1984). |
Del Regato et al., “Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study,” I.J. Radiation Oncology Biol. Physics 26:197-201 (1993). |
Gottesman et al., “Failure of open radioactive 125iodine implantation to control localized prostate cancer: A study of 41 patients,” J. Urology 146:1317-1320 (1991). |
Kaye et al., “Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach,” J. Urology 168:1020-1025 (1995). |
Kiernan et al., “Histochemical demonstaration of unsaturated hydrophilic lipids with palladium chloride,” J. Histochemistry and Cytochemistry 25:200-205 (1977). |
Kumar et al., “Vicryl carrier for I-125 seeds: percutaneous transperineal insertion1,” Radiology 159:276 (1986). |
Martsev et al., “Modification of monoclonal and polyclonal IgG with palladium (II) coproporphyrin I: stimulatory and inhibitory functional effects induced by two different methods,” J. Immunological Methods 186:293-304 (1995). |
Peschel et al., “Iodine-125 implants for carcimona of the prostate,” Int. J. Radiat. Oncol. Biol. Phys. 11:1777-1781 (1985). |
Weyrich et al., “Iodine 125 seed implants for prostatic carcinoma,” Urology 41:122-126 (1993). |
Wimmer et al., “The antitumor activity of some palladium(II) complexes with chelating ligands*,” Anticancer Research 9:791-794 (1989). |
Zelefsky et al., “Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer,” J. of Urology 158:23-30 (1997). |